Search

Your search keyword '"Fabiane Santos de Lima"' showing total 2 results
Start Over Author "Fabiane Santos de Lima" Language english
2 results on '"Fabiane Santos de Lima"'

1. Rapid development of seizures and PRES in a COVID-19 patient

Author

Fabiane Santos de Lima, Sara Klein, Faten El Ammar, Shasha Wu, Sandra Rose, James X. Tao, and Naoum P. Issa

Subjects
COVID-19, PRES, Posterior reversible encephalopathy syndrome, SARS-CoV-2, Case report, Neurology. Diseases of the nervous system, RC346-429, Neurophysiology and neuropsychology, QP351-495
Abstract

Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease.

Published
2021
Full Text
View/download PDF

2. Rapid development of seizures and PRES in a COVID-19 patient

Author

Sandra Rose, Shasha Wu, Fabiane Santos de Lima, Sara Klein, James X. Tao, Faten El Ammar, and Naoum P. Issa

Subjects
Neurophysiology and neuropsychology, Pediatrics, medicine.medical_specialty, 2019-20 coronavirus outbreak, Neurological injury, Coronavirus disease 2019 (COVID-19), Disease, PRES, Behavioral Neuroscience, Case report, Medicine, In patient, RC346-429, business.industry, SARS-CoV-2, Mortality rate, QP351-495, COVID-19, Posterior reversible encephalopathy syndrome, medicine.disease, Neurology, Neurological dysfunction, Neurology (clinical), Neurology. Diseases of the nervous system, business
Abstract

Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results